Swiss National Bank’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Swiss National Bank’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-139,366	Closed	-$930K	–	2623
2023 Q3	$930K	Buy	139,366 +2,500	+2%	+$20.8K	﹤0.01%	2283
2023 Q2	$1.24M	Hold	136,866	–	–	﹤0.01%	2181
2023 Q1	$995K	Sell	136,866 -13,900	-9%	-$103K	﹤0.01%	2254
2022 Q4	$1.1M	Sell	150,766 -8,600	-5%	-$63.8K	﹤0.01%	2295
2022 Q3	$1.23M	Buy	159,366 +63,800	+67%	+$542K	﹤0.01%	2214
2022 Q2	$651K	Buy	95,566 +10,400	+12%	+$79.6K	﹤0.01%	2543
2022 Q1	$679K	Buy	85,166 +5,800	+7%	+$36.8K	﹤0.01%	2532
2021 Q4	$444K	Buy	+79,366	New	+$596K	﹤0.01%	2683

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Swiss National Bank's PNT Position: Q4 2023 in Review

Swiss National Bank sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 139,366 shares — an estimated $930K sold.

Swiss National Bank first reported a position in PNT in Q4 2021 and held it in 8 quarters. The position peaked at $1.24M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Swiss National Bank reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Swiss National Bank sold 139,366 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $930K.
Swiss National Bank first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Swiss National Bank's POINT Biopharma Global Inc. Common Stock position peaked at $1.24M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.